| Titre |
A Comprehensive and Observational Myeloproliferative Neoplasms Registry in the Province of Quebec (MPN Registry) |
| Protocole ID |
Registre des NMP (CINC424BCA04T) |
| ClinicalTrials.gov ID |
|
| Type(s) de cancer |
NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide |
| Phase |
Autres |
| Institution |
CISSS DE LAVAL
 HOPITAL DE LA CITE-DE-LA-SANTE
1755 boul. René-Laennec, Laval, QC, H7M 3L9
|
| Ville |
Laval |
| Investigateur(trice) principal(e) |
Dre Danielle Talbot
|
| Coordonnateur(trice) |
Solange Tremblay
450-668-1010 poste 23603
|
| Statut |
 Actif en recrutement |
| Critètes d'éligibilité |
All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
- Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
- Are 18 years of age or older;
- Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable.
|
| Critètes d'exclusion |
Patients who meet any of the following criteria will be excluded from participation:
- Life expectancy of less than 3 months for a condition not related to MPN;
- Patients suffering of CML.
|
Groupe d'étude en oncologie du Québec